green light go go ahead advance yes streetlight
Pharma

Viridian set for 1-on-1 vs. Amgen after FDA approval of Lumvoa

Viridian has secured an FDA nod for Lumvoa to treat the eye-bulging condition TED, triggering competition with Amgen’s blockbuster Tepezza.
Kevin Dunleavy Jun 29, 2026 8:32am
A chessboard with blocks that read MA

After trial fail, Teravance is bought out by Zymeworks for $929M

Jun 29, 2026 11:30am
FDA stop sign

FDA snubs Sobi’s gout drug over manufacturing issues

Jun 29, 2026 11:04am
Food and Drug Administration

Regulatory tracker: FDA starts review of Sandoz's generic GLP-1

Jun 29, 2026 10:30am
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Lilly works to build Foundayo awareness

Jun 29, 2026 9:15am
FDA

FDA issues Form 483 to Dr. Reddy's plant in India

Jun 26, 2026 11:40am
More News

EC begins antitrust probe into Sanofi's flu shot campaign

Jun 26, 2026 11:20am

Europe's CHMP reverses endorsement of Amgen's Tavneos

Jun 26, 2026 11:07am

Solid tumor CAR-T, Pfizer-Innovent, China deals—Fierce Pharma Asia

Jun 26, 2026 8:51am

BeOne boosts support for Blood Cancer United with $5M commitment

Jun 26, 2026 3:57am